These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2785819)

  • 41. Neuropeptides in relation to suicidal behavior in depression.
    Roy A
    Neuropsychobiology; 1993; 28(4):184-6. PubMed ID: 7903797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for corticotropin-releasing factor, neurotensin, and somatostatin in the neural pathway from the central nucleus of the amygdala to the parabrachial nucleus.
    Moga MM; Gray TS
    J Comp Neurol; 1985 Nov; 241(3):275-84. PubMed ID: 2868027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder.
    Geracioti TD; Baker DG; Kasckow JW; Strawn JR; Jeffrey Mulchahey J; Dashevsky BA; Horn PS; Ekhator NN
    Psychoneuroendocrinology; 2008 May; 33(4):416-24. PubMed ID: 18295412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD; Orth DN; Ekhator NN; Blumenkopf B; Loosen PT
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1325-30. PubMed ID: 1317385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
    Kaye WH; Gwirtsman HE; George DT; Ebert MH; Jimerson DC; Tomai TP; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1987 Feb; 64(2):203-8. PubMed ID: 3491830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.
    Nikisch G; Baumann P; Liu T; Mathé AA
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1051-61. PubMed ID: 22008251
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoreactive parathyroid hormone and calcitonin in children's cerebrospinal fluid.
    Saggese G; Bertelloni S; Baroncelli GI; Abadessa A; Macchia P; Bottone U
    Horm Res; 1986; 23(3):177-80. PubMed ID: 3949289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW
    Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone.
    Vythilingam M; Anderson GM; Owens MJ; Halaszynski TM; Bremner JD; Carpenter LL; Heninger GR; Nemeroff CB; Charney DS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4138-45. PubMed ID: 11095445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution.
    Strömbom U; Krotkiewski M; Blennow K; Månsson JE; Ekman R; Björntorp P
    Int J Obes Relat Metab Disord; 1996 Apr; 20(4):361-8. PubMed ID: 8680464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture.
    Nishino S; Mignot E; Benson KL; Zarcone VP
    Psychiatry Res; 1998 May; 78(3):141-50. PubMed ID: 9657418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM; Bissette G; Arato M; O'Connor L; Nemeroff CB
    Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cord blood levels of corticotropin-releasing factor.
    Nagashima K; Yagi H; Yunoki H; Noji T; Kuroume T
    Biol Neonate; 1987; 51(1):1-4. PubMed ID: 2950934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of pituitary beta-endorphin secretagogues on the concentration of beta-endorphin in rat cerebrospinal fluid: evidence for a role of vasopressin in the regulation of brain beta-endorphin release.
    Barna I; Sweep CG; Veldhuis HD; Wiegant VM; De Wied D
    Neuroendocrinology; 1990 Jan; 51(1):104-10. PubMed ID: 2137562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of uteroplacental insufficiency upon brain neuropeptide Y and corticotropin-releasing factor gene expression and concentrations.
    Rajakumar PA; He J; Simmons RA; Devaskar SU
    Pediatr Res; 1998 Aug; 44(2):168-74. PubMed ID: 9702909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women.
    Florio P; Busacca M; Vignali M; Viganò P; Woods RJ; Lowry PJ; Genazzani AR; Luisi S; Santuz M; Petraglia F
    J Endocrinol Invest; 1998 Jan; 21(1):37-42. PubMed ID: 9633021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrospinal-fluid neuropeptides: a biochemical subgrouping approach.
    Banki CM; Karmacsi L; Bissette G; Nemeroff CB
    Neuropsychobiology; 1992; 26(1-2):37-42. PubMed ID: 1361969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptides and electroconvulsive treatment.
    Mathé AA
    J ECT; 1999 Mar; 15(1):60-75. PubMed ID: 10189619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maternal Cerebrospinal Fluid Glutamate in Response to Variable Foraging Demand: Relationship to Cerebrospinal Fluid Serotonin Metabolites in Grown Offspring.
    Coplan JD; Gupta NK; Flynn SK; Reiner WJ; Gaita D; Fulton SL; Rozenboym AV; Tang JE; Cooper TB; Mann JJ
    Chronic Stress (Thousand Oaks); 2018; 2():. PubMed ID: 30246167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced CSF neurotensin concentration in drug-free schizophrenic patients.
    Lindström LH; Widerlöv E; Bisette G; Nemeroff C
    Schizophr Res; 1988; 1(1):55-9. PubMed ID: 3154507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.